Drug Type Radiolabeled antibody, Diagnostic radiopharmaceuticals |
Synonyms Iodine-124-labelled F-16 scFv antibody, Monoclonal antibody F-16-I-124, Monoclonal antibody F16 I 124 + [4] |
Target |
Action inhibitors, enhancers |
Mechanism tenascin inhibitors(Tenascin inhibitors), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 2 | - | - | |
Neoplasms | Phase 2 | - | - | |
Solid tumor | Phase 2 | Italy | - | - |